In certain cancer types, including BC, high receptor tyrosine kinase-like orphan receptor 1 (ROR1) expression levels have been reported, making it an interesting target for immunotherapies such as CAR-T cell therapy.39 This evidence concerns the gene ROR1 and breast cancer.